Advertisement

The Clinically Detected and Palpable Thyroid Nodule

  • Whitney GoldnerEmail author
  • Anery Patel
Chapter

Abstract

A subset of thyroid nodules can present as a palpable neck mass or with clinical symptoms suggestive of a thyroid nodule. Initial evaluation should include a detailed history identifying high-risk populations as well as specific risk factors and symptoms suggestive of thyroid nodules or thyroid cancer. It is essential to perform a comprehensive thyroid and neck examination. This chapter provides a review of the detailed evaluation of a patient with clinically detected thyroid nodule.

Keywords

Thyroid Thyroid nodule Thyroid cancer Palpation Physical examination Neck mass Dysphagia Hoarseness Compressive symptoms 

Abbreviations

ATC

Anaplastic thyroid cancer

FAP

Familial adenomatous polyposis

FTC

Follicular thyroid cancer

FMTC

Familial medullary thyroid cancer

MEN

Multiple endocrine neoplasia

MTC

Medullary thyroid cancer

PTC

Papillary thyroid cancer

References

  1. 1.
    Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993;328(8):553–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Rojeski MT, Gharib H. Nodular thyroid disease. Evaluation and management. N Engl J Med. 1985;313(7):428–36.CrossRefPubMedGoogle Scholar
  3. 3.
    Stanicic J, Prpic M, Jukic T, Boric M, Kusic Z. Thyroid nodularity–true epidemic or improved diagnostics. Acta Clin Croat. 2009;48(4):413–8.PubMedGoogle Scholar
  4. 4.
    Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126(3):226–31.CrossRefPubMedGoogle Scholar
  5. 5.
    Wiest PW, Hartshorne MF, Inskip PD, Crooks LA, Vela BS, Telepak RJ, et al. Thyroid palpation versus high-resolution thyroid ultrasonography in the detection of nodules. J Ultrasound Med Off J Am Inst Ultrasound Med. 1998;17(8):487–96.Google Scholar
  6. 6.
    Brander A, Viikinkoski P, Tuuhea J, Voutilainen L, Kivisaari L. Clinical versus ultrasound examination of the thyroid gland in common clinical practice. J Clin Ultrasound. 1992;20(1):37–42.CrossRefPubMedGoogle Scholar
  7. 7.
    Daniels GH. Physical examination of the thyroid gland. In: Braverman LE, Utiger RD, editors. Werner & Ingbar’s the thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lipincott Williams & Wilkins; 2000. p. 462–6.Google Scholar
  8. 8.
    Brander AE, Viikinkoski VP, Nickels JI, Kivisaari LM. Importance of thyroid abnormalities detected at US screening: a 5-year follow-up. Radiology. 2000;215(3):801–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Burguera B, Gharib H. Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am. 2000;29(1):187–203.CrossRefPubMedGoogle Scholar
  10. 10.
    Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Gharib H, Papini E, Valcavi R, Baskin HJ, Crescenzi A, Dottorini ME, et al. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract Off J Am Coll of Endocrinol Am Ass Clin Endocrinol. 2006;12(1):63–102.Google Scholar
  12. 12.
    Morris LG, Sikora AG, Tosteson TD, Davies L. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid Off J AmThyroid Ass. 2013;23(7):885–91.CrossRefGoogle Scholar
  13. 13.
    Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992;93(4):363–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid Off J AmThyroid Ass. 2009;19(11):1167–214.CrossRefGoogle Scholar
  15. 15.
    Feng X, Milas M, O’Malley M, LaGuardia L, Berber E, Jin J, et al. Characteristics of benign and malignant thyroid disease in familial adenomatous polyposis patients and recommendations for disease surveillance. Thyroid Off J AmThyroid Ass. 2015;25(3):325–32.CrossRefGoogle Scholar
  16. 16.
    Jarrar AM, Milas M, Mitchell J, Laguardia L, O’Malley M, Berber E, et al. Screening for thyroid cancer in patients with familial adenomatous polyposis. Ann Surg. 2011;253(3):515–21.CrossRefPubMedGoogle Scholar
  17. 17.
    Mazeh H, Sippel RS. Familial nonmedullary thyroid carcinoma. Thyroid Off J AmThyroid Ass. 2013;23(9):1049–56.CrossRefGoogle Scholar
  18. 18.
    Stratakis CA, Courcoutsakis NA, Abati A, Filie A, Doppman JL, Carney JA, et al. Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex). J Clin Endocrinol Metab. 1997;82(7):2037–43.CrossRefPubMedGoogle Scholar
  19. 19.
    Ishikawa Y, Sugano H, Matsumoto T, Furuichi Y, Miller RW, Goto M. Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race. Cancer. 1999;85(6):1345–52.CrossRefPubMedGoogle Scholar
  20. 20.
    Ron E, Kleinerman RA, LiVolsi VA, Fraumeni Jr JF. Familial nonmedullary thyroid cancer. Oncology. 1991;48(4):309–11.CrossRefPubMedGoogle Scholar
  21. 21.
    Sippel RS, Caron NR, Clark OH. An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg. 2007;31(5):924–33.CrossRefPubMedGoogle Scholar
  22. 22.
    Rowland KJ, Moley JF. Hereditary thyroid cancer syndromes and genetic testing. J Surg Oncol. 2015;111(1):51–60.CrossRefPubMedGoogle Scholar
  23. 23.
    Wells Jr SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid Off J AmThyroid Ass. 2015;25(6):567–610.CrossRefGoogle Scholar
  24. 24.
    Davies L, Randolph G. Evidence-based evaluation of the thyroid nodule. Otolaryngol Clin North Am. 2014;47(4):461–74.CrossRefPubMedGoogle Scholar
  25. 25.
    Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid Off J AmThyroid Ass. 2011;21(6):593–646.CrossRefGoogle Scholar
  26. 26.
    Dolman PJ. Evaluating Graves’ orbitopathy. Best Pract Res Clin Endocrinol Metab. 2012;26(3):229–48.CrossRefPubMedGoogle Scholar
  27. 27.
    Fatourechi V. Thyroid dermopathy and acropachy. Best Pract Res Clin Endocrinol Metab. 2012;26(4):553–65.CrossRefPubMedGoogle Scholar
  28. 28.
    Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid Off J AmThyroid Ass. 2012;22(12):1200–35.CrossRefGoogle Scholar
  29. 29.
    Nose V. Thyroid cancer of follicular cell origin in inherited tumor syndromes. Adv Anat Pathol. 2010;17(6):428–36.CrossRefPubMedGoogle Scholar
  30. 30.
    DeGroot LJ. Clinical review 2: diagnostic approach and management of patients exposed to irradiation to the thyroid. J Clin Endocrinol Metab. 1989;69(5):925–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Furukawa K, Preston D, Funamoto S, Yonehara S, Ito M, Tokuoka S, et al. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. Int J Cancer. 2013;132(5):1222–6.CrossRefPubMedGoogle Scholar
  32. 32.
    Fogelfeld L, Wiviott MB, Shore-Freedman E, Blend M, Bekerman C, Pinsky S, et al. Recurrence of thyroid nodules after surgical removal in patients irradiated in childhood for benign conditions. N Engl J Med. 1989;320(13):835–40.CrossRefPubMedGoogle Scholar
  33. 33.
    Laurberg P, Bulow Pedersen I, Knudsen N, Ovesen L, Andersen S. Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid Off J AmThyroid Ass. 2001;11(5):457–69.CrossRefGoogle Scholar
  34. 34.
    Braverman LE. Iodine and the thyroid: 33 years of study. Thyroid Off J AmThyroid Ass. 1994;4(3):351–6.CrossRefGoogle Scholar
  35. 35.
    Zimmermann MB, Galetti V. Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res. 2015;8:8.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Salvatore D, Davies TF, Schlumberger M-J, Hay ID, Larsen PR. Thyroid physiology and diagnostic evaluation of patients with thyroid disoders. In: Williams textbook of endocrinology. 12th ed. Philadelphia: Saunders Elsevier; 2011. p. 327–61.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Division of Diabetes, Endocrinology and Metabolism, Department of Internal MedicineUniversity of Nebraska Medical CenterOmahaUSA

Personalised recommendations